Kelly H. Skelton

Affiliations: 
Emory University, Atlanta, GA 
Area:
Psychiatry
Google:
"Kelly Skelton"
Cross-listing: Neurotree

Parents

Sign in to add mentor
Charles B. Nemeroff grad student 2000 Emory
 (The effects of benzodiazepine administration and withdrawal on corticotropin -releasing factor and urocortin neuronal systems in the rat.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wingo AP, Briscione M, Norrholm SD, et al. (2017) Psychological resilience is associated with more intact social functioning in veterans with post-traumatic stress disorder and depression. Psychiatry Research. 249: 206-211
Skelton K, Ressler KJ, Norrholm SD, et al. (2012) PTSD and gene variants: new pathways and new thinking. Neuropharmacology. 62: 628-37
Ferdinand LG, Kelly UA, Skelton K, et al. (2011) An evolving integrative treatment program for military sexual trauma (MST) and one veteran's experience. Issues in Mental Health Nursing. 32: 552-9
Skelton KH, Oren D, Gutman DA, et al. (2007) The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal. European Journal of Pharmacology. 571: 17-24
Skelton KH, Gutman DA, Thrivikraman KV, et al. (2007) The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal. Psychopharmacology. 192: 385-96
Skelton KH, Nemeroff CB, Owens MJ. (2004) Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 9303-12
Gilmor ML, Skelton KH, Nemeroff CB, et al. (2003) The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems. The Journal of Pharmacology and Experimental Therapeutics. 305: 434-9
Gutman DA, Owens MJ, Skelton KH, et al. (2003) The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. The Journal of Pharmacology and Experimental Therapeutics. 304: 874-80
O'Brien D, Skelton KH, Owens MJ, et al. (2001) Are CRF receptor antagonists potential antidepressants? Human Psychopharmacology. 16: 81-87
O'Brien D, Skelton KH, Owens MJ, et al. (2001) Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis Human Psychopharmacology. 16: 89-93
See more...